Login / Signup

Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes.

Carmen Hierro-BujalanceMonica Garcia-Alloza
Published in: Neural regeneration research (2023)
Keyphrases
  • type diabetes
  • white matter
  • resting state
  • cognitive decline
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • functional connectivity
  • metabolic syndrome
  • adipose tissue
  • weight loss